258 related articles for article (PubMed ID: 6228344)
1. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
2. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
3. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
4. [Biosynthesis and biodegradation of GM2 ganglioside].
Hirabayashi Y; Kasakura H; Matsumoto M
Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
[No Abstract] [Full Text] [Related]
5. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
7. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
8. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
[TBL] [Abstract][Full Text] [Related]
9. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
10. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
Yutaka T; Okada S; Kato T; Yabuuhi H
Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
[TBL] [Abstract][Full Text] [Related]
11. Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.
Novak A; Callahan JW; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):215-23. PubMed ID: 8123671
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
14. Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.
Yutaka T; Kato T; Okada S; Yabuuci H
Clin Genet; 1982 Oct; 22(4):165-71. PubMed ID: 6217929
[TBL] [Abstract][Full Text] [Related]
15. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
16. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
17. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
[TBL] [Abstract][Full Text] [Related]
19. The GM2-gangliosidoses and the elucidation of the beta-hexosaminidase system.
Sandhoff K
Adv Genet; 2001; 44():67-91. PubMed ID: 11597000
[No Abstract] [Full Text] [Related]
20. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
